MAK Capital Tells Evotec to List US Unit Worth Over €1 billion
Activist fund MAK Capital, led by Michael A. Kaufman, has urged the leadership of German biotech firm Evotec SE to …
Real-time market intelligence across asset classes
AI-curated news influencing COST price, sentiment, and trend
Activist fund MAK Capital, led by Michael A. Kaufman, has urged the leadership of German biotech firm Evotec SE to …
Investors are getting this stock at a sale price right now.
Target stock is moving higher after a CEO change. Can it keep going?
Shares of this massive retailer have risen 13% in 2026, while the overall market is down.
Multi-Provider AI Analysis